Wird geladen...
Phospholipase D1 is upregulated by vorinostat and confers resistance to vorinostat in glioblastoma
Glioblastoma (GBM) is an aggressive brain tumor and drug resistance remains a major barrier for therapeutics. Epigenetic alterations are implicated in GBM pathogenesis, and epigenetic modulators including histone deacetylase (HDAC) inhibitors are exploited as promising anticancer therapies. Here, we...
Gespeichert in:
| Veröffentlicht in: | J Cell Physiol |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7692931/ https://ncbi.nlm.nih.gov/pubmed/32869317 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcp.29882 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|